ATAXION
Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic diseases. Located in Cambridge, Massachusetts, Ataxion was founded in April 2013 out of the Atlas Venture seed program by Dr. Josh Resnick and Atlas Venture Development Corporation Managing Director and Ataxion Board Member David Grayzel, MD.
ATAXION
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2013-04-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.ataxiontherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
(617)588-2644
Total Funding:
17 M USD
Similar Organizations
Anebulo Pharmaceuticals
Anebulo is a biotech company developing novel solutions for people suffering from cannabinoid overdose and substance addiction.
Apic Bio
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.
Aviceda Therapeutics
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Cortene
Cortene is a clinical-stage biopharmaceutical company focused on developing treatments for chronic fatigue syndrome and other diseases.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Glycostem Therapeutics
Glycostem is a clinical stage biotech company developing off-the shelf allogeneic cellular immunotherapy using Natural Killer (NK) cells.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Tetris Pharma
UK based niche speciality pharmaceutical company building a European platform to market a range of prescription products
Current Advisors List
Current Employees Featured
Founder
Investors List
Biogen
Biogen investment in Series A - Ataxion
Atlas Venture
Atlas Venture investment in Series A - Ataxion
Official Site Inspections
http://www.ataxiontherapeutics.com
Unable to get host informations!!!
More informations about "Ataxion"
Ataxion - Crunchbase Company Profile & Funding
Organization. Ataxion . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Ataxion is a discovery-stage biopharmaceutical โฆSee details»
Ataxion Company Profile 2024: Valuation, Investors, Acquisition
Ataxion General Information Description. Developer of novel small-molecule therapeutics designed for neurological diseases. The company's novel small-molecule therapeutics offers a โฆSee details»
Ataxion Inc - Company Profile and News - Bloomberg Markets
Company profile page for Ataxion Inc including stock price, company news, executives, board members, and contact informationSee details»
Ataxion - Products, Competitors, Financials, Employees, โฆ
Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic diseases in partnership with Biogen. Use the CB โฆSee details»
Ataxion Company Profile - Office Locations, Competitors ... - Craft
See insights on Ataxion including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Ataxion, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Ataxion, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Ataxion - VentureRadar
Molecular Imaging USA Privately Held Molecular Imaging, Inc. is a specialty contract research organization (CRO) located in Ann Arbor, Michigan. Molecular Imaging employs a wide array โฆSee details»
Cadent Therapeutics acquires Ataxion - 2017-03-07 - Crunchbase
Mar 7, 2017 Disposition of Acquired Organization Subsidiary; Recent News. Edit Recent News Section. News โข Mar 8, 2017. Clal Biotech co Luk buys Ataxion Therapeutics . Unlock even โฆSee details»
Ataxion - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 17, 2014: Series A - โฆSee details»
Ataxion - Company Profile - Tracxn
Nov 4, 2024 Ataxion - Discovering and developing small molecule therapeutics targeting ion channel with central nervous system.. This company is not active anymore. Raised a total โฆSee details»
Saniona AB: Saniona announces a merger of its spinout company โฆ
PRESS RELEASE March 6, 2017 Saniona, a leading biotech company within ion-channel research, today announces that its spinout company Ataxion has engaged into a merger with โฆSee details»
M&As this week: Ataxion, Kasten, Heat Biologics
Mar 9, 2017 Ataxion, a spinout company of biotechnology firm Saniona, is set to merge with Luc Therapeutics.. The merged company will continue to operate as Luc Therapeutics, in which โฆSee details»
BioCentury - Ataxion, Luc Therapeutics deal
Mar 17, 2017 Ataxion will merge with Luc; the newco will retain Luc's name and focus on precision medicine for neurological and psychiatric diseases. Its pipeline includes programs to โฆSee details»
Neurological Drug Developer Cadent Therapeutics Collects $40 โฆ
Nov 16, 2018 Last year Luc Therapeutics and Ataxion Therapeutics merged to form Cadent. The consolidation created a company with a diversified pipeline that appeals to investors, said โฆSee details»
Ataxion Management Team - CB Insights
Explore {Ataxion's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Ataxion Announces $17M Series A Financing from Atlas Venture โฆ
Mar 17, 2014 Ataxion, Inc, a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic diseases, has secured Series A โฆSee details»
Ataxiontherapeutics Cyber Security Rating & Vendor Risk Report ...
View Ataxiontherapeutics's cyber security risk rating against other vendors' scores. Explore cyber risks, data breaches, and cybersecurity incidents involving Ataxiontherapeutics. ... Learn what โฆSee details»
Biogen, Atlas Venture collaborate on treatment for ataxia
Mar 17, 2014 Biogen and Atlas Venture are investing $17 million in Ataxion, a life sciences industry startup to develop treatments for inherited forms of ataxia, an orphan disease.See details»
Ataxiontherapeutics Cyber Security Rating & Vendor Risk Report ...
View Ataxiontherapeutics's cyber security risk rating against other vendors' scores. Explore cyber risks, data breaches, and cybersecurity incidents involving AtaxiontherapeuticsSee details»
Ataxion, Inc.: ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ
ไบ่งฃAtaxion, Inc.ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็1็ฏๆฐ้ปใSee details»